CLINICAL_TRIALS
trial_result
· 2010-03-08
Clinical Trial Update: Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL [Phase 1]
Summary
Phase 1 dose-escalation pharmacodynamic study of CNF1010 in ZAP-70 positive chronic lymphocytic leukemia; the study is terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: TERMINATED